ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : HAART/AIDS
Australian State/Territory : VIC
Status : Closed
Clear All
Filter by Field of Research
Medical Virology (3)
Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies) (1)
Infectious Diseases (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (5)
Filter by Status
Closed (5)
Filter by Scheme
NHMRC Project Grants (3)
NHMRC Postgraduate Scholarships (1)
Programs (1)
Filter by Country
Australia (5)
Filter by Australian State/Territory
VIC (5)
NSW (2)
  • Researchers (0)
  • Funded Activities (5)
  • Organisations (0)
  • Funded Activity

    Evaluating The Role Of A4a7 Integrin Expression On CD4+ And CD8+ T Cells In SIV Infection In Pigtail Macques.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $91,262.00
    More information
    Funded Activity

    Elucidating The Mechanism Of Action Of Dendrimer Nanoparticles Against HIV

    Funder
    National Health and Medical Research Council
    Funding Amount
    $559,354.00
    Summary
    Dendrimers are nanoparticles with highly branched structures and they are being developed as topical microbicides to prevent the sexual transmission of HIV. This study will determine how dendrimers block HIV entry into host cells so that we can design more effective inhibitors and microbicides.
    More information
    Funded Activity

    Pathogenesis Of Persistent Human Virus Infections Of Global Significance

    Funder
    National Health and Medical Research Council
    Funding Amount
    $6,571,328.00
    Summary
    The study will investigate why humans cannot eradicate particular viruses (HIV-AIDS, cytomegalovirus and herpes simplex virus), the long term effects of these viruses and ways to improve control. Current treatments can only partly suppress the levels of these viruses, because they persist in certain parts of the body called reservoirs, only to resurge later causing disease. Thus, the overall aim of the research program is to discover the mechanisms by which these viruses are able to successfully .... The study will investigate why humans cannot eradicate particular viruses (HIV-AIDS, cytomegalovirus and herpes simplex virus), the long term effects of these viruses and ways to improve control. Current treatments can only partly suppress the levels of these viruses, because they persist in certain parts of the body called reservoirs, only to resurge later causing disease. Thus, the overall aim of the research program is to discover the mechanisms by which these viruses are able to successfully persist within reservoirs in the human body. The research program brings together a group of 6 leading scientists and clinicians located at 3 sites in 2 Australian cities. The team is comprised of experts in the study of HIV-AIDS, cytomegalovirus and herpes simplex virus who will combine their knowledge and expertise to speed up the process of research on these viruses that are of major health importance. Studies will also utilise a number of cutting edge technologies that now make it possible to much more rapidly and precisely determine how viruses cause disease. Advances in our understanding of how viruses persist may form the basis for treatments aimed at controlling persistent infections and the serious diseases caused by these viruses.
    Read more Read less
    More information
    Funded Activity

    The Role Of Chemokines In Establishing HIV Latency

    Funder
    National Health and Medical Research Council
    Funding Amount
    $372,049.00
    Summary
    Although antiviral therapy is effective in controlling HIV, therapy must be continued life-long because the virus cannot be cleared from long lived infected CD4+ T cells that are silently or latently infected. In this proposal we will explore the mechanism of how HIV can enter these resting CD4+ T-cells and establish long lived latent infection. Understanding this process may potentially lead to new strategies to cure HIV infection.
    More information
    Funded Activity

    Mechanisms Underlying APOBEC3G Restriction Of HIV-1

    Funder
    National Health and Medical Research Council
    Funding Amount
    $540,075.00
    Summary
    In the fight against worldwide HIV-AIDS, understanding natural cell defenses to the HIV virus may identify new virus targets and strategies to block HIV in humans. Here, we will use state-of-the-art, high resolution, fluorescent microscopy to understand how the recently identified cell protein, APOBEC3G, blocks the HIV life cycle in human cells. We anticipate that APOBEC3G will stop HIV from invading the nucleus of human cells to defend against HIV, a strategy we can apply to new therapies.
    More information

    Showing 1-5 of 5 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback